600530.SS · ST交昂
China A-shares · RS rating 4 · As of 2026-10-14
| Price | 3.57 CNY |
|---|---|
| 1-day change | -0.8% |
| RS rating (overall / 1M / 3M / 12M) | 4 / 34 / 10 / 3 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 24 / 15 / 16 |
| Industry group (rank) | Medical-Generic Drugs (40) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +3.4% |
| Distance from 52-week high | +59.5% |
| Market cap (USD) | $427.6M |